135 related articles for article (PubMed ID: 33237244)
1. Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Nascimento GJFD; Silva LPD; Matos FR; Silva TAD; Medeiros SRB; Souza LB; Freitas RA
Braz Oral Res; 2020; 35():e019. PubMed ID: 33237244
[TBL] [Abstract][Full Text] [Related]
2. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
Chaudhary AK; Pandya S; Mehrotra R; Singh M; Singh M
Biomarkers; 2011 Nov; 16(7):577-86. PubMed ID: 21958210
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
4. Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Malik MA; Sharma KL; Zargar SA; Mittal B
Saudi J Gastroenterol; 2011; 17(5):301-6. PubMed ID: 21912055
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in MMP 2, 3, 7, and 9 genes and the susceptibility and clinical outcome of cervical cancer in a Chinese Han population.
Xie B; Zhang Z; Wang H; Chen Z; Wang Y; Liang H; Yang G; Yang X; Zhang H
Tumour Biol; 2016 Apr; 37(4):4883-8. PubMed ID: 26526578
[TBL] [Abstract][Full Text] [Related]
6. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
7. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
[TBL] [Abstract][Full Text] [Related]
8. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
9. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder.
Bobińska K; Szemraj J; Czarny P; Gałecki P
J Affect Disord; 2016 Nov; 205():119-129. PubMed ID: 27434116
[TBL] [Abstract][Full Text] [Related]
10. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
[TBL] [Abstract][Full Text] [Related]
11. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T
Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283
[TBL] [Abstract][Full Text] [Related]
12. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia.
Rahimi Z; Kazemian L; Malek-Khosravi S; Najafi F; Rahimi Z
Arch Gynecol Obstet; 2015 Jan; 291(1):45-51. PubMed ID: 25063248
[TBL] [Abstract][Full Text] [Related]
14. rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
Pençe S; Özbek E; Ozan Tiryakioğlu N; Ersoy Tunali N; Pençe HH; Tunali H
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):46-52. PubMed ID: 28980922
[TBL] [Abstract][Full Text] [Related]
15. Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Rahimi Z; Abdan Z; Rahimi Z; Razazian N; Shiri H; Vaisi-Raygani A; Shakiba E; Vessal M; Moradi MT
Immunol Invest; 2016 Aug; 45(6):543-52. PubMed ID: 27409770
[TBL] [Abstract][Full Text] [Related]
16. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
17. Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study.
Liu JW; Chen DQ
Kaohsiung J Med Sci; 2018 Nov; 34(11):634-642. PubMed ID: 30392570
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
Yi YC; Chou PT; Chen LY; Kuo WH; Ho ES; Han CP; Yang SF
Clin Chem Lab Med; 2010 Mar; 48(3):337-44. PubMed ID: 20113256
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk.
Guan X; Wang X; Luo H; Wu J; Zhang X; Wu J
Med Sci Monit; 2014 Nov; 20():2269-74. PubMed ID: 25391977
[TBL] [Abstract][Full Text] [Related]
20. Analysis of
Wadowska K; Błasiak P; Rzechonek A; Śliwińska-Mossoń M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
